Transition from solid tissue to high-viability single-cell suspensions with the TissueGrinder. An enzyme-free, standardized mechanical approach designed for the future of personalized medicine.
As a BioTech-SpinOff from Fraunhofer IPA in Mannheim we are proud to have been part of Fraunhofer VENTURE’s accelerator program AHEAD.
The TissueGrinder is a proven solution across three continents, empowering the world’s leading scientists in their quest to advance the next generation of healthcare discoveries.
Academic
Institutes
University
Hospitals
Biotech &
CROs
Pharma
R&D
Core Technology
A standardized, mechanical approach to generating high-viability single-cell suspensions from solid tissues. Achieve consistent, reproducible results without the transcriptional changes or variable artifacts introduced by chemical enzymes.
Fast Forward Discoveries (FFX) develops technologies that enable reliable access to high-quality single cells—the critical foundation for modern biology and personalized healthcare.
As a spin-off founded by experts in biology, biotechnology, and engineering, we aim to make single-cell preparation more accessible, robust, and scalable.
Interested in evaluating the TissueGrinder in your laboratory?
Book SupportFFX joins interdisciplinary expertise in Life Science, Biotechnology, Physics, Engineering, Software and Medical Devices to bring your research and medical applications to a new level.
Theodor-Kutzer-Ufer 1-3
CUBEX41
68167 Mannheim
Germany
* Required fields
The data sent will only be processed for the purpose of handling your request. You can find further information in our data protection information.
